Invesco BLDRS Europe Select ADR Index FundLatest Invesco BLDRS Europe Select ADR Index Fund News and UpdatesCompany & Industry OverviewsHow Is Novartis’s Lucentis Positioned after 1H17?In 1H17, Novartis’s (NVS) Lucentis reported revenues of around $922 million, which is a ~1% decline on a year-over-year (or YoY) basis.
Company & Industry OverviewsHow Is Novartis’s Lucentis Positioned after 1H17?In 1H17, Novartis’s (NVS) Lucentis reported revenues of around $922 million, which is a ~1% decline on a year-over-year (or YoY) basis.
